Oxytocic Pharmaceuticals Market, By Treatment Type (Pre-Eclampsia/Eclampsia, Postpartum Hemorrhage, and Others), End Use (Hospitals, Maternity Centre, and Clinics), and By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

The Global Oxytocic Pharmaceuticals Market size was valued at USD 112.4 million in 2019 and is anticipated to grow at a CAGR of 17.4% during the forecast period. Oxytocic pharmaceuticals are used for baby caring mothers to diagnose and reduce the pain of uterine. These pharmaceuticals enhance and control the uterine contractions and reduce or control the bleeding after childbirth. Oxytocic pharmaceuticals are also called as vaccinium occycoccus, oxycoccus macrocarpus, vaccinium edule, and vaccinium macrocarpon. Oxytocic pharmaceuticals are given in injection form in muscle and in external form through a vein. Oxytocic pharmaceuticals are given in various treatments which include postpartum hemorrhage, pre-eclampsia, hypertension during pregnancy, treatment of autism, inevitable abortion, and excessive bleeding following vaginal delivery.

Increase in a number of labor induction across the globe, increase in innovation and development in child birth drugs and therapies, a growing number of pregnancy-related complications, growing concerns of stress, child abortion, and miscarriage in developing economies, technological advancement in oxytocic pharmaceuticals, is further expected to drive the growth of oxytocic pharmaceuticals market. Also, an increase in innovation and development in oxytocic pharmaceuticals, increase in the spending capacity of individual, government support and subsidies for the innovation in pharmaceuticals, and increase in demand for oxytocic pharmaceuticals in emerging economies. Therefore, the effect of this factor on the oxytocic pharmaceuticals market is expected to increase soon with continuously evolving technologies.

Key Factors Impacting the Growth of Oxytocic Pharmaceuticals Market:

  • Increase in healthcare infrastructure
  • Increasing demand from developing countries
  • Increase in innovation and development in oxytocic pharmaceuticals
  • Increasing incidences of post-partum haemorrhage
  • Increase in the trend of delivery in hospitals

The oxytocic pharmaceuticals market segmentation is based on treatment type, end use, and region. The leading pharmaceutical leaders are looking to the oxytocic pharmaceuticals for various new treatments. The oxytocic pharmaceuticals market is currently witnessing high growth due to increased demand in order to provide better healthcare in the shortest possible time and expenses.

Treatment Type Outlook:

The treatment type for the generation of revenues in the global oxytocic pharmaceuticals market is postpartum hemorrhage. The postpartum hemorrhage segment is predicted to account for the largest share in the oxytocic pharmaceuticals market. This can be due to a growing number of baby birth, increase in age of mothers with stress, uncomfortable, sore and tired, and increase in a number of haemorrhages.

End Use Outlook:

Based on end use, the oxytocic pharmaceuticals market has been segmented into hospitals, maternity centre, and clinics. As per the current market scenario, the online pharmacy segment has covered the largest oxytocic pharmaceuticals market share and is projected to register a higher CAGR during the forecast period. The increase in demand for child birth in hospitals, increase in consumer preference for treatment in hospitals, increase in a number of hospitals, and government investment for the development of hospitals are the factors that are expected to increase the demand for oxytocic pharmaceuticals during the forecast period.

Regional Outlook:

Based on the region, the global oxytocic pharmaceuticals market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In terms of revenue, North America holds a dominant position in the global oxytocic pharmaceuticals market. North is expected to hold a dominant position in the market due to favorable government policies for the development of child and women healthcare, growing prevalence of induced labor, increasing innovation and development in oxytocic pharmaceuticals, a collaboration of government associations and key players for the development of new drugs and treatment, favorable reimbursement policy, and the presence of well-developed healthcare infrastructure. Moreover, Europe has substantial growth in the market due to growing demand for treatment in hospitals, increase in research and development centers in Germany and France, growing awareness regarding pregnancy is expected to increase the demand for oxytocic pharmaceuticals in the region. Furthermore, the Asia Pacific is expected to register the highest growth rate in the global oxytocic pharmaceuticals market during the forecast period. This growth can be accredited to several factors, such as growing healthcare infrastructure in the region, government spending for the development of women and child care, increase in innovation and development in oxytocic pharmaceuticals.

The report analyzes factors affecting the oxytocic pharmaceuticals market from both demand and supply side and further analyses market dynamics affecting the market during the forecast year such as driver, restrain, opportunities and future trends. The report also provides comprehensive Porter’s model analysis on the Oxytocic pharmaceuticals market for all six regions namely; North America, Western Europe, Eastern Europe, Asia Pacific, Middle East and the Rest of the world.

Competitive Landscape

Major companies are investing in research and development. Key market players are also adopting inorganic development strategies like as acquisition of local brands. Similarly, other business models such as joint venture and market entry strategies are helping prominent vendors to make their presence felt in the Oxytocic pharmaceuticals market and increase their product portfolio. The key leading players in the market include JHP Pharmaceuticals, LLC, APP Pharmaceuticals, LLC, Baxter Healthcare Corporation, Pfizer Inc., Abbott, Novartis Pharmaceuticals Corporation, Teva Parenteral Medicines Inc., Ferring B.V., Biofutura SpA, and Fresenius Kabi AG.

This report also includes the profiles of key oxytocic pharmaceuticals market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Oxytocic Pharmaceuticals Market:

  • In September 2019, Fresenius Kabi AG opened a new research and development facility in Eysins, Switzerland. The new research and development centre focuses on new product development in oxytocic pharmaceuticals and other maternity products

What Does This Report Provide?

This report provides a detailed understanding of the global oxytocic pharmaceuticals market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Treatment Type

  • Pre-eclampsia/Eclampsia
  • Postpartum Hemorrhage
  • Others

By End Use

  • Hospitals
  • Maternity Centre
  • Clinics

By Region:

  • North America Oxytocic Pharmaceuticals Market
    • By Country (US, Canada, Mexico)
    • By Treatment Type
    • By End Use
  • Europe Oxytocic Pharmaceuticals Market
    • By Country (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)
    • By Treatment Type
    • By End Use
  • Asia Pacific Oxytocic Pharmaceuticals Market
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Treatment Type
    • By End Use
  • Middle East & Africa Oxytocic Pharmaceuticals Market
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East & Africa)
    • By Treatment Type
    • By End Use
  • South America Oxytocic Pharmaceuticals Market
    • By Country (Brazil, Argentina, Colombia, Rest of South America)
    • By Treatment Type
    • By End Use

Reasons to Buy This Report:

  • Market size estimation of the oxytocic pharmaceuticals market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com